Predicting response to neoadjuvant therapy for rectal cancer

Tech Coloproctol. 2014 Aug;18(8):683-4. doi: 10.1007/s10151-014-1162-8. Epub 2014 May 20.

Authors

S Pucciarelli¹, L Bacigalupo, I Maretto

Affiliation

¹ Department of Surgery Oncology and Gastroenterology, Clinica Chirurgica I, University of Padova, Via Giustiniani, 2, 35128, Padua, Italy, puc@unipd.it.

PMID: 24840244
DOI: 10.1007/s10151-014-1162-8

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adenocarcinoma / therapy*
Antineoplastic Agents / therapeutic use*
Diagnostic Imaging*
Female
Humans
Male
Positron-Emission Tomography / methods*
Rectal Neoplasms / therapy*

Substances

Antineoplastic Agents